Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 578

1.

Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.

Fonarow GC, Zhao X, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Xian Y, Hernandez AF, Peterson ED, Schwamm LH.

JAMA. 2014 Apr 23-30;311(16):1632-40. doi: 10.1001/jama.2014.3203.

PMID:
24756513
2.

Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.

Sauser K, Levine DA, Nickles AV, Reeves MJ.

JAMA Neurol. 2014 Sep;71(9):1155-61. doi: 10.1001/jamaneurol.2014.1528.

PMID:
25023407
3.

Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke.

Saver JL, Fonarow GC, Smith EE, Reeves MJ, Grau-Sepulveda MV, Pan W, Olson DM, Hernandez AF, Peterson ED, Schwamm LH.

JAMA. 2013 Jun 19;309(23):2480-8. doi: 10.1001/jama.2013.6959.

PMID:
23780461
4.

Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke.

Lin CB, Cox M, Olson DM, Britz GW, Constable M, Fonarow GC, Schwamm L, Peterson ED, Shah BR.

J Am Heart Assoc. 2015 Jul 22;4(7). pii: e001298. doi: 10.1161/JAHA.114.001298.

5.

Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke.

Xian Y, Smith EE, Zhao X, Peterson ED, Olson DM, Hernandez AF, Bhatt DL, Saver JL, Schwamm LH, Fonarow GC.

Stroke. 2014 May;45(5):1387-95. doi: 10.1161/STROKEAHA.113.003898. Epub 2014 Apr 8.

6.

24/7 Neurocritical Care Nurse Practitioner Coverage Reduced Door-to-Needle Time in Stroke Patients Treated with Tissue Plasminogen Activator.

Moran JL, Nakagawa K, Asai SM, Koenig MA.

J Stroke Cerebrovasc Dis. 2016 May;25(5):1148-52. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.033. Epub 2016 Feb 19.

7.

Simple text-messaging intervention is associated with improved door-to-needle times for acute ischemic stroke.

Burnett MM, Zimmermann L, Coralic Z, Quon T, Whetstone W, Kim AS.

Stroke. 2014 Dec;45(12):3714-6. doi: 10.1161/STROKEAHA.114.007294. Epub 2014 Oct 28.

8.

Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.

Xian Y, Liang L, Smith EE, Schwamm LH, Reeves MJ, Olson DM, Hernandez AF, Fonarow GC, Peterson ED.

JAMA. 2012 Jun 27;307(24):2600-8. doi: 10.1001/jama.2012.6756.

PMID:
22735429
9.

Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.

Lin CB, Peterson ED, Smith EE, Saver JL, Liang L, Xian Y, Olson DM, Shah BR, Hernandez AF, Schwamm LH, Fonarow GC.

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):514-22. doi: 10.1161/CIRCOUTCOMES.112.965210. Epub 2012 Jul 10.

10.

Delays in Door-to-Needle Times and Their Impact on Treatment Time and Outcomes in Get With The Guidelines-Stroke.

Kamal N, Sheng S, Xian Y, Matsouaka R, Hill MD, Bhatt DL, Saver JL, Reeves MJ, Fonarow GC, Schwamm LH, Smith EE.

Stroke. 2017 Apr;48(4):946-954. doi: 10.1161/STROKEAHA.116.015712. Epub 2017 Feb 22.

PMID:
28228574
11.

Improving door-to-needle times: a single center validation of the target stroke hypothesis.

Ruff IM, Ali SF, Goldstein JN, Lev M, Copen WA, McIntyre J, Rost NS, Schwamm LH.

Stroke. 2014 Feb;45(2):504-8. doi: 10.1161/STROKEAHA.113.004073. Epub 2014 Jan 7.

12.

Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.

Yeo LL, Paliwal P, Teoh HL, Seet RC, Chan BP, Wakerley B, Liang S, Rathakrishnan R, Chong VF, Ting EY, Sharma VK.

J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e590-6. doi: 10.1016/j.jstrokecerebrovasdis.2013.07.024. Epub 2013 Aug 15.

PMID:
23954601
13.

Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.

Schwamm LH, Ali SF, Reeves MJ, Smith EE, Saver JL, Messe S, Bhatt DL, Grau-Sepulveda MV, Peterson ED, Fonarow GC.

Circ Cardiovasc Qual Outcomes. 2013 Sep 1;6(5):543-9. doi: 10.1161/CIRCOUTCOMES.111.000303.

14.

Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.

Romano JG, Smith EE, Liang L, Gardener H, Camp S, Shuey L, Cook A, Campo-Bustillo I, Khatri P, Bhatt DL, Fonarow GC, Sacco RL, Schwamm LH.

JAMA Neurol. 2015 Apr;72(4):423-31. doi: 10.1001/jamaneurol.2014.4354.

PMID:
25642650
15.

Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.

Xian Y, Federspiel JJ, Grau-Sepulveda M, Hernandez AF, Schwamm LH, Bhatt DL, Smith EE, Reeves MJ, Thomas L, Webb L, Bettger JP, Laskowitz DT, Fonarow GC, Peterson ED.

JAMA Neurol. 2016 Jan;73(1):50-9. doi: 10.1001/jamaneurol.2015.3106.

PMID:
26551916
16.

Screening with MRI for Accurate and Rapid Stroke Treatment: SMART.

Shah S, Luby M, Poole K, Morella T, Keller E, Benson RT, Lynch JK, Nadareishvili Z, Hsia AW.

Neurology. 2015 Jun 16;84(24):2438-44. doi: 10.1212/WNL.0000000000001678. Epub 2015 May 13.

17.

Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative.

Fonarow GC, Smith EE, Saver JL, Reeves MJ, Hernandez AF, Peterson ED, Sacco RL, Schwamm LH.

Stroke. 2011 Oct;42(10):2983-9. doi: 10.1161/STROKEAHA.111.621342. Epub 2011 Sep 1.

18.

CODE FAST: a quality improvement initiative to reduce door-to-needle times.

Busby L, Owada K, Dhungana S, Zimmermann S, Coppola V, Ruban R, Horn C, Rochestie D, Khaldi A, Hormes JT, Gupta R.

J Neurointerv Surg. 2016 Jul;8(7):661-4. doi: 10.1136/neurintsurg-2015-011806. Epub 2015 Jun 18.

PMID:
26089402
19.

Use of tissue-type plasminogen activator before and after publication of the European Cooperative Acute Stroke Study III in Get With The Guidelines-Stroke.

Messé SR, Fonarow GC, Smith EE, Kaltenbach L, Olson DM, Kasner SE, Schwamm LH.

Circ Cardiovasc Qual Outcomes. 2012 May;5(3):321-6. doi: 10.1161/CIRCOUTCOMES.111.964064. Epub 2012 May 1.

20.

Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.

Xian Y, Xu H, Lytle B, Blevins J, Peterson ED, Hernandez AF, Smith EE, Saver JL, Messé SR, Paulsen M, Suter RE, Reeves MJ, Jauch EC, Schwamm LH, Fonarow GC.

Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1). pii: e003227. doi: 10.1161/CIRCOUTCOMES.116.003227.

PMID:
28096207

Supplemental Content

Support Center